Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
NewAmsterdam Pharma Announces 2024 Strategic Priorities
-
The Government of Ecuador Approves Atico’s Concession Extension Until 2049
-
Peak Bio, Inc. Awarded Patent with Broad Coverage for Thailanstatin-ADC platform technology (PH-1) a Payload with Novel Immunomodulatory Effects that Target RNA Splicing
-
ZeroFox Awarded $289M from U.S. Office of Personnel Management for Digital Identity Protection Services
-
authID Continues Growth Momentum with Strong Q4 Sales
-
Super League to Host Virtual Non-Deal Roadshow Webinar on Wednesday, January 17, 2024, at 11:00 a.m. Eastern Time
-
Casa Systems Appoints Former Google Executive Santanu Dasgupta as Chief Technology Officer
-
Constellium to Showcase Cutting-Edge Solutions for Aluminium Automotive Structures at CES 2024 in Las Vegas
-
Well+Good Launches Well/Mess: A New Approach to January Wellness
-
Ocuphire Pharma Receives FDA Agreement Under Special Protocol Assessment for LYNX-2 Phase 3 Trial of Phentolamine Ophthalmic Solution for the Treatment of Decreased Visual Acuity under Dim (mesopic) L
-
Third Harmonic Bio Appoints Christopher Murphy as Chief Financial and Business Officer and Provides Business Update
-
TransUnion Announces Enhanced Identity Graph for Marketing Solutions
-
Cocrystal Pharma Provides an Update on the Clinical Development of its Novel, Broad-Spectrum Antiviral Investigational Candidates
-
Solid Biosciences to Participate at 42nd Annual J.P. Morgan Healthcare Conference
-
Acrivon Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
Black Diamond Therapeutics Announces Corporate Update and Expected 2024 Milestones
-
Aspen Group, Inc. to Report Financial Results for the Second Quarter of Fiscal Year 2024 on January 18, 2024
-
Alimera Completes Recruitment for the Synchronicity Study
-
Boehringer Ingelheim licenses multiple Dark Antigens® from Enara Bio to develop off-the-shelf immunotherapies for non-small cell lung cancer (NSCLC)
-
EG427 Announces New Preclinical Results from Multiple Studies of EG110A in Neurogenic Detrusor Overactivity (NDO) and Overactive Bladder (OAB)
-
ALK to become sole manufacturer and distributor of skin antigen test for penicillin allergy
-
Former Biogen CEO Michel Vounatsos Joins Quris-AI Board
-
Recursion Adds New Chemical Entity Targeting Fibrotic Diseases to Late Discovery Pipeline
-
Zerify Provides 2024 Projections and Updates on Recently Announced Transactions-Deals
-
ITM Announces Operational Readiness for NOVA Facility, the World’s Largest Lutetium-177 Production Site
-
Form 8.3 - [abrdn EUROPEAN LOGISTICS INCOME PLC - 03 01 2024] - (CGWL)
-
ZyVersa Therapeutics Announces Equity Research Coverage Initiated by Noble Capital Markets
-
Form 8.3 - [LXi REIT PLC - 03 01 2024] - (CGWL)
-
Form 8.3 - DX (Group) Plc
-
Repayments, Realkredit Danmark A/S
-
Medigus: Revoltz Opens for Pre-Orders of its Revolutionary Micro Mobility EV
-
Fixing of coupon rates - Nykredit Realkredit A/S
-
aiMotive Unveils aiSim 5: Pioneering Next-Gen AutoGI for ADAS/AD Simulation
-
K.Hill Project Granted Environmental Authorisation and Submits Mining Licence Application
-
SL Green Realty Corp. to Release Fourth Quarter 2023 Financial Results After Market Close on January 24, 2024
-
One Bullion Ltd. Corporate Update
-
AppTech Payments Corp. to Attend Consumer Electronics Show in Las Vegas January 9-12, 2024
-
Knight Therapeutics Announces Product Launch for IMVEXXY® in Canada
-
Alaska Energy Metals Announces Assays From Surface Rock Sampling and Geophysical Survey Results at the Canwell Property, Nikolai Nickel Project, Alaska
-
Sensei Biotherapeutics Provides Corporate Update and Highlights Key Upcoming Milestones
-
Ormat Completed the Acquisition of Contracted Operating Geothermal and Solar Assets From Enel Green Power North America
-
Kiniksa Pharmaceuticals Provides Corporate Update
-
Safe Harbor Financial Originates $9 Million First Lien Secured Loan for Major, MSO-Operated Cultivation Facility in Denver, Colorado
-
Cognition Therapeutics CEO Issues Letter to Shareholders
-
DevvStream To Engage with Municipal Governments in Los Angeles, Phoenix, Philadelphia, San Antonio, and 25 Additional U.S. Cities to Advance Technological Solutions to Climate Change
-
Cibus Enters into a Latin America Collaboration Agreement with Interoc to deliver rice growers an innovative rice weed control system
-
nCino to Participate in Upcoming Investor Conference
-
Verrica Pharmaceuticals Announces Receipt of Minutes from Type C Meeting with FDA Regarding Clinical Development of YCANTH™ for the Treatment of Common Warts
-
Form 8.3 - LXi REIT plc
-
Form 8.3 - Smart Metering Systems plc
